title: The preferential occurrence of FLT3-TKD mutations in inv(16) AML and impact on survival outcome: a combined analysis of 1053 core-binding factor AML patients.
authors.forename: Chung H
authors.initials: CH
authors.lastname: Kok
authors.forename: Anna L
authors.initials: AL
authors.lastname: Brown
authors.forename: Michelle
authors.initials: M
authors.lastname: Perugini
authors.forename: Diana G
authors.initials: DG
authors.lastname: Iarossi
authors.forename: Ian D
authors.initials: ID
authors.lastname: Lewis
authors.forename: Richard J
authors.initials: RJ
authors.lastname: D'Andrea
mesh_terms: D000328:Adult; D050660:Core Binding Factors / Q000235:genetics*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000401:mortality; D009154:Mutation / Q000235:genetics*; D011379:Prognosis; D016019:Survival Analysis; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics*
chemical_list: D050660:Core Binding Factors; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3